PTSD linked with cardiovascular disease and cancer, study shows

Posttraumatic stress disorder (PTSD) was associated with cardiovascular disease and cancer, as well as the metabolic syndrome, in a new study.

In the Journal of Neuroscience Research study of 84 individuals diagnosed with PTSD (39 victims of terrorist attacks and 45 victims of other traumatic events), males were more likely to have circulatory and metabolic complications, whereas females had a higher prevalence of benign and malignant cancers.

A longer duration of PTSD was associated with the development of cardiovascular disease, while PTSD following terrorist attacks was associated with a higher cancer prevalence.

"An explanation of why victims of terrorism may have a higher cancer prevalence than victims of other traumatic events, such as accidents, may be the intentional infliction of harm on the victim causing a more dysregulated stress response. A challenge for the future is monitoring the physical health of victims over time and understanding psychological and neurobiological processes producing this effect," said co-author Dr. Andrea Pozza, of the Santa Maria alle Scotte University Hospital, in Italy. "Longer untreated PTSD was associated with higher prevalence of cardiovascular disease regardless of the event type: this suggests the importance of early intervention for PTSD and also education programs for the general population to make people aware about PTSD early warning signs and how to recognize them."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients